BETA nonprofit public democratic european moderated

Search

#HealthInequality
BBC 3w

In Liverpool, health leaders are addressing the historical neglect of women's healthcare, highlighted by alarming statistics showing that women in the city experience significantly poorer health outcomes and face numerous barriers to care, prompting calls for systemic changes and improved access to services. #WomensHealth #HealthInequality #HealthcareAccess #GB

'We need to respond to Liverpool women's health needs more easily'

A recent study indicates that while average height in Great Britain has been rising, particularly during the pandemic, this increase is primarily linked to growing childhood obesity rates, especially among poorer children, rather than improvements in health, highlighting widening socioeconomic disparities. #ChildObesity #HealthInequality #Epidemiology #GB #EU #RU #TR #HU #CY #FI

How widespread is obesity across Europe?

In Italia, le disuguaglianze nell'accesso alle cure pediatriche compromettono il diritto alla salute dei bambini, rendendo necessario affrontare questo problema non solo come un tema sanitario, ma anche come una questione di responsabilità civile e politica. #ChildHealth #HealthInequality #SocialJustice

Cure ai bimbi? Dipende da dove si nasce

Fast die Hälfte der Deutschen im mittleren Lebensalter leidet an zwei oder mehr chronischen Erkrankungen, wobei regionale Unterschiede und Risikofaktoren wie Bewegungsmangel, Rauchen und Alkoholkonsum eine bedeutende Rolle spielen. #ChronicDiseases #Multimorbidity #HealthInequality

Fast jeder Zweite ab 50 hat mehrere chronische Krankheiten - wo es am schlimmsten ist

An international investigation reveals that Merck's commercial strategy for its cancer drug Keytruda, which costs over R$20,000 in Brazil, employs complex legal and pricing tactics to control access, thereby making it increasingly inaccessible to many patients worldwide, despite its significant role in treating various cancers and generating billions in revenue. #CancerTreatment #PharmaceuticalIndustry #HealthInequality

Como um remédio de ponta contra câncer se tornou inacessível